Genomic correlates of acquired resistance to PD-(L)1 blockade in patients with advanced non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...

Although genotyping errors affect most data and can markedly influence the biological conclusions of a study, they are too often neglected. Genotyping errors can result from very diverse, complex, and ...

Allied Market Research published a report, titled, "Genotyping Market by Product (Instruments, Reagents and Kits and Software ...

Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have demonstrated potent activity against TKI resistance mediated by EGFR T790M. We studied whether ...

Large-scale association studies by genotyping many single nucleotide polymorphisms (SNPs), in individuals with well characterized phenotypes, are considered as promising methods to identify the cause ...

The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...

A new microfluidic chip simplifies detecting and quantifying DNA by analyzing electrical impedance signals that vary based on DNA flowing across a biosensor inside the chip. The proof-of-concept ...

In recent years, the rise of next-generation sequencing (NGS) has unlocked new dimensions in variant detection. However; single nucleotide polymorphism (SNP) genotyping often remains dependent on ...

The National Academies of Sciences, Engineering, and Medicine will convene a planning committee to conduct a two-day public workshop on law enforcement use of probabilistic genotyping, forensic DNA ...

Your next favorite true crime podcast might have some new forensics jargon to make sense of. Researchers in Australia have developed a new way to identify humans – similar to how we do with DNA and ...

DiamiR Biosciences Corp., a developer of blood-based diagnostics for brain health, and Aptorum Group Limited (NASDAQ:APM), a clinical-stage biopharmaceutical firm, announced that New York State’s ...